ASCO GU 2008 - Correlating Androgen Levels And Steroidogenic Enzyme Expression In Castration-Resistant Prostate Cancer (CRPC) Metastases
Main Category: Prostate / Prostate CancerAlso Included In: Endocrinology; Urology / Nephrology
Article Date: 16 Feb 2008 - 1:00 PDT
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
4 (1 votes) |
UroToday.com - Dr. Mostaghel reviewed the potential sources of tissue androgens from the androgen metabolic pathway. This includes the uptake and conversion of circulating adrenal androgens, and the de novo androgen biosynthesis of androgens from cholesterol, progesterone or earlier precursors.
Tumor tissue was obtained from the warm autopsy study at the University of Washington. Testosterone levels within castration resistant metastases were measured and are significantly elevated compared to primary prostate tissues in these autopsy samples. Expression of steroidogenic transcripts in CRPC metastases is greater than primary tumors. SQLE and LSS are 2 genes involved early in the cholesterol synthesis process that were elevated in these samples. Also increased cholesterol membrane translocation and metabolism genes were altered. A correlation between androgen levels and transcript expression in CRPC metastases was made. Groups of genes that correlated with DHT or testosterone in CRPC metastasis were found. They were fitted into the synthesis pathways to correlate with mechanism and thus may represent targets. The simultaneous targeting of multiple enzymes comprising the intracrine steroidogenic pathway may thus provide clinical utility.
Presented by E. A. Mostaghel at the American Society of Clinical Oncology (ASCO) - 2008 Genitourinary Cancers Symposium - A Multidisciplinary Approach - February 14-16, 2008 San Francisco, California, USA
Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS Professor & Chairman Department of Urology University of California, Davis, School of Medicine Sacramento, CA
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
----------------------------
Copyright © 2007 - UroToday
Reproduced for Medical News Today with permission of UroToday.
----------------------------
Visit our prostate / prostate cancer section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/97596.php>
APA
http://www.medicalnewstoday.com/releases/97596.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




